(1)
Yikilmaz, T. N.; Dirim, A.; Ayva, E. S.; Ozdemir, H.; Ozkardes, H. Clinical Use of Tumor Markers for the Detection and Prognosis of Bladder Carcinoma: A Comparison of CD44, Cytokeratin 20 and Survivin. Urol J 2016, 13, 2677-2683.